411 related articles for article (PubMed ID: 27487959)
21. The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4.
Giusti S; Lin Y; Sogbetun F; Nakhoul N; Liu S; Shi L; Batuman V
Am J Med Sci; 2021 Nov; 362(5):453-461. PubMed ID: 34033809
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
Wu B; Li D; Xu T; Luo M; He Z; Li Y
Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
[TBL] [Abstract][Full Text] [Related]
23. The relationship between proton pump inhibitors and renal disease.
Morschel CF; Mafra D; Eduardo JCC
J Bras Nefrol; 2018; 40(3):301-306. PubMed ID: 30010692
[TBL] [Abstract][Full Text] [Related]
24. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
25. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
Al-Aly Z; Maddukuri G; Xie Y
Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
[TBL] [Abstract][Full Text] [Related]
26. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
[TBL] [Abstract][Full Text] [Related]
27. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin.
Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK
J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119
[TBL] [Abstract][Full Text] [Related]
28. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
29. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.
Cholin L; Ashour T; Mehdi A; Taliercio JJ; Daou R; Arrigain S; Schold JD; Thomas G; Nally J; Nakhoul NL; Nakhoul GN
BMC Nephrol; 2021 Jul; 22(1):264. PubMed ID: 34266395
[TBL] [Abstract][Full Text] [Related]
30. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
31. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
[TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors use and risk of chronic kidney disease and end-stage renal disease.
Vengrus CS; Delfino VD; Bignardi PR
Minerva Urol Nephrol; 2021 Aug; 73(4):462-470. PubMed ID: 33769018
[TBL] [Abstract][Full Text] [Related]
34. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
35. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series.
Muriithi AK; Leung N; Valeri AM; Cornell LD; Sethi S; Fidler ME; Nasr SH
Am J Kidney Dis; 2014 Oct; 64(4):558-66. PubMed ID: 24927897
[TBL] [Abstract][Full Text] [Related]
36. Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort.
Dos Santos AS; de Menezes ST; Silva IR; Oliveira WN; Pereira ML; Mill JG; Barreto SM; Figueiredo RC
BMC Nephrol; 2023 Sep; 24(1):285. PubMed ID: 37770872
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
[TBL] [Abstract][Full Text] [Related]
38. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
39. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
40. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
El Chamieh C; Larabi IA; Laville SM; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Pecoits-Filho R; Lange C; Stengel B; Alencar De Pinho N; Alvarez JC; Massy ZA; Liabeuf S;
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
